Page last updated: 2024-09-03

garenoxacin and mk-0429

garenoxacin has been researched along with mk-0429 in 1 studies

Compound Research Comparison

Studies (garenoxacin)	Trials (garenoxacin)	Recent Studies (post-2010) (garenoxacin)	Studies (mk-0429)	Trials (mk-0429)	Recent Studies (post-2010) (mk-0429)
195	19	46	6	0	2

Protein Interaction Comparison

Protein	Taxonomy	mk-0429 (IC50)
Integrin beta-3	Homo sapiens (human)	0.1627
Integrin beta-1	Homo sapiens (human)	2.5367
Integrin alpha-V	Homo sapiens (human)	0.1627
Integrin alpha-5	Homo sapiens (human)	2.5367

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW	1

Other Studies

1 other study(ies) available for garenoxacin and mk-0429

Article	Year
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics. Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:7 Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results	2006

Article

Year

Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.

Drug metabolism and disposition: the biological fate of chemicals, 2006, Volume: 34, Issue:7

Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results

2006